Susceptibility Genetic Variants Associated With Early-Onset Colorectal Cancer
Menée sur deux cohortes de patients atteints d'un cancer colorectal (191 patients d'âge inférieur à 50 ans, 1 264 d'âge supérieur à 65 ans), cette étude identifie des variants génétiques associés à un risque accru de cancer colorectal précoce
Colorectal cancer (CRC) is the second most common cancer in Western countries. Hereditary forms only correspond to 5% of CRC burden. Recently, genome-wide association studies (GWAS) have identified common, low-penetrant CRC genetic susceptibility loci. Early-onset CRC (CRC<50 years old.) is especially suggestive of hereditary predisposition although 85-90% of heritability still remains unidentified. CRC<50 patients (n=191) were compared with a late-onset CRC group (CRC>65 years old) (n=1,264). CRC susceptibility variants at 8q23.3 (rs16892766), 8q24.21 (rs6983267), 10p14 (rs10795668), 11q23.1 (rs3802842), 15q13.3 (rs4779584), 18q21 (rs4939827), 14q22.2 (rs4444235), 16q22.1 (rs9929218), 19q13.1 (rs10411210) and 20p12.3 (rs961253) were genotyped in all DNA samples. A genotype-phenotype correlation with clinical and pathological characteristics in both groups was performed. Risk allele carriers for rs3802842 (OR=1.5, 95%CI 1.1-2.05, P=0.0096, dominant model) and rs4779584 (OR=1.39, 95%CI 1.02-1.9, P=0.0396, dominant model) were more frequent in the CRC<50 group, whereas homozygotes for rs10795668 risk allele were also more frequent in the early-onset CRC (P=0.02, codominant model). Regarding early-onset cases, 14q22 (rs4444235), 11q23 (rs3802842) and 20p12 (rs961253) variants were more associated with family history of CRC or tumors of the Lynch syndrome (LS) spectrum excluding CRC. In our entire cohort, sum of risk alleles was significantly higher in patients with a CRC family history (OR=1.40, 95%CI 1.06-1.85, p=0.01). In conclusion, variants at 10p14 (rs10795668), 11q23.1 (rs3802842) and 15q13.3 (rs4779584) may have a predominant role in predisposition to early-onset CRC. Association of CRC susceptibility variants with some patient's familiar and personal features could be relevant for screening and surveillance strategies in this high-risk group and it should be explored in further studies.
http://carcin.oxfordjournals.org/content/early/2012/01/10/carcin.bgs009.abstract